Richard Baldridge, president & COO, ViaSat was elected chairman of the Board of Directors of EvoNexus. Baldridge leads corporate strategy and operations for ViaSat, a global provider of satellite broadband and wireless services, infrastructure, and technology. During his tenure, ViaSat has grown organically and through acquisitions by more than a factor of 10, to a multi-billion dollar enterprise.

Rob Douglas, president & COO, ResMed, was elected vice chairman of the Board of Directors of EvoNexus. ResMed is a global medical device company in the treatment of sleep-disordered breathing. Douglas has over 25 years experience in operations and marketing for high-tech medical device and e-commerce solution sector leaders.

Derek Aberle, president of Qualcomm Inc, was elected to the EvoNexus Board of Directors. As president of Qualcomm, Aberle as a member of Qualcomm’s executive committee since 2008, helped drive Qualcomm’s overall global strategy and in recent years has been instrumental to evolving and expanding Qualcomm’s business in China.

DLA Piper has also taken a board seat at EvoNexus with the election of senior partner, Larry Nishnick. Larry’s recent representation of public and private companies includes Qualcomm, ViaSat, Provide Commerce, Jack-in-the-Box, Cross-Fit, NuVasive Life Technologies, Cypher Genomics, Halozyme Therapeutics, and a vast number of private emerging growth technology companies.

“EvoNexus is fortunate to have this leadership and the finest Board of Directors of any incubator in the entire country. Their financial and strategic support of the ventures launched and their dedication to the mission of EvoNexus is impacting the growth of the innovation economy,” says EvoNexus CEO and co-founder, Rory Moore, in a release. “The integration of new technologies into markets is accelerated when established corporations partner with startup communities.”

EvoNexus is a non-profit technology incubator with locations in San Diego and Irvine. Under its model, EvoNexus startups receive mentorship, access to capital, and full services without giving up equity or paying fees. Its startups enjoy office and lab space provided by real estate developer The Irvine Company. In just over 7 years, EvoNexus portfolio companies have raised over $1.19 billion in funding and outcomes and 18 startups have been acquired.